Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-28

Clinical Trial Update: Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT

View source ↗

Summary

Clinical trial update examining albumin effects on colloid osmotic pressure and endothelial damage in patients with end-stage liver disease undergoing orthotopi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin

Snippet

Sponsor: Medical University of Vienna | Conditions: Transplant-Related Disorder | Status: COMPLETED